Evidence map›Paper›PMID 34321854›Full record

ArticleWorld journal of gastroenterology2021

Effect of gastric microbiota on quadruple

Zhan-Yue Niu, Si-Zhu Li, Yan-Yan Shi, Yan Xue

Abstract read
In one paragraph

Article in World journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. The impact ofFrontiers in cellular and infection microbiology · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Gastric microbiota dysbiosis andFrontiers in microbiology · 2023
    Review
  10. Gastrointestinal microbiome andWorld journal of gastroenterology · 2022
    Article
  11. Review
  12. RefractoryFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhan-Yue NiuDepartment of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.
Si-Zhu LiDepartment of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.
Yan-Yan ShiResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.
Yan XueDepartment of Gastroenterology, Peking University Third Hospital, Beijing 100191, China. xueyanby@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

aimThe aim was to investigate the characteristics of the gastric microbiota with

methodsPatients with

resultsThe eradication rate of all the patients was 95.5% (171/179). Twenty-four patients were enrolled in the study after propensity-matched scoring. There were eight cases in the failure group (patients who did not respond well to therapy) and 16 cases in the success group. The majority phyla in the two groups were the same, and included Proteobacteria, Bacteroides, Firmicutes, Actinomycetes, and Fusobacteria. The microbial diversity in the failure group had a decreasing trend (

conclusionThe effectiveness of quadruple

Indexed as

Helicobacter InfectionsHelicobacter pyloriMicrobiotaAmoxicillinAnti-Bacterial AgentsBismuthDrug Therapy, CombinationHumansProton Pump InhibitorsTreatment OutcomeAmoxicillinAnti-Bacterial AgentsBismuthProton Pump InhibitorsEradicationGastric microbiotaHelicobacter pyloriInfluence factorspropensity matchingQuadruple therapy

Identifiers

PMID34321854
PMCPMC8291010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.